| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/15/2005 | EP1539233A1 Super humanized antibodies |
| 06/15/2005 | EP1539231A1 Iscom preparation and use thereof |
| 06/15/2005 | EP1539230A2 Administration of therapeutic viruses |
| 06/15/2005 | EP1539229A2 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
| 06/15/2005 | EP1539228A2 Novel composition and methods for the treatment of immune related diseases |
| 06/15/2005 | EP1539223A2 Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines comprising heat shock protein-peptide complexes or alpha-2-macroglobulin-peptide complexes |
| 06/15/2005 | EP1539215A2 Adjuvant-free peptide vaccine |
| 06/15/2005 | EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/15/2005 | EP1539200A2 Method for the treatment of multiple sclerosis |
| 06/15/2005 | EP1539197A2 Treatment of tumor cells for use in immunotherapy of cancer |
| 06/15/2005 | EP1539194A2 Cancer therapy using beta glucan and antibodies |
| 06/15/2005 | EP1539190A1 Biosynthesis of hif |
| 06/15/2005 | EP1539142A2 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer s disease |
| 06/15/2005 | EP1539107A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 06/15/2005 | EP1539106A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/15/2005 | EP1539097A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 06/15/2005 | EP1539041A1 Devices delivering therapeutic agents and methods regarding the same |
| 06/15/2005 | EP1538900A2 Cancer vaccines containing epitopes of oncofetal antigen |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/15/2005 | EP1267922B1 Pneumococcus polysaccharide conjugates for use as vaccine against tetanus and diphtheria |
| 06/15/2005 | EP1248836B1 Method for preparing vaccines by using hybrid cells |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0977587B1 Chimeric flavivirus vaccines |
| 06/15/2005 | EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 06/15/2005 | EP0955948B1 Induction of immunological tolerance |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | EP0753061B1 Oral vaccine compositions against infections with yersinia pestis |
| 06/15/2005 | CN1628249A Paramycobacterial diagnostics and vaccines |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628167A Interleukin-2 gene transferred lymphokine activated killer cells |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1627960A Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides |
| 06/15/2005 | CN1627924A Medical device with coating that promotes endothelial cell adherence and differentiation |
| 06/15/2005 | CN1626669A Preparation of full-length human antibody |
| 06/15/2005 | CN1626544A Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacterin |
| 06/15/2005 | CN1626242A Combined vaccine composed of viral of Japanese b encephalitis and vaccine of brain fever cocci |
| 06/15/2005 | CN1626241A Proteins derived from white spot syndrome virus and uses thereof |
| 06/15/2005 | CN1626239A Use of TGF-beta and growth factor in treatment and prevention of intestinal mucosa diseases |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/14/2005 | US6906169 Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| 06/14/2005 | US6905845 Isolated nucleic acids; allergies sensitivity |
| 06/14/2005 | US6905835 Assay for anti transglutaminase antibodies detection useful in celicac disease diagnosis |
| 06/14/2005 | US6905712 Intensifier of immunology response |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905686 Active immunization for treatment of alzheimer's disease |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905682 Hybrid nucleic acids, ant antibodies thereof; insecticide |
| 06/14/2005 | US6905681 Methods for selectively stimulating proliferation of T cells |
| 06/14/2005 | US6905680 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 06/14/2005 | US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 06/14/2005 | CA2400318C Botulinum toxin pharmaceutical compositions |
| 06/14/2005 | CA2308142C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 06/14/2005 | CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/14/2005 | CA2246708C Vaccine for b-cell malignancies |
| 06/14/2005 | CA2164088C Plasmids suitable for gene therapy |
| 06/10/2005 | CA2489266A1 Reagents for detecting efavirenz |
| 06/09/2005 | WO2005052166A1 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases. |
| 06/09/2005 | WO2005052128A2 Mrna transfected antigen presenting cells |
| 06/09/2005 | WO2005052126A2 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
| 06/09/2005 | WO2005052122A2 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 06/09/2005 | WO2005052119A2 Adjuvants of immune response |
| 06/09/2005 | WO2005052115A2 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | WO2005052005A1 Anti-igfr1 antibody therapeutic combinations |
| 06/09/2005 | WO2005052004A2 Compositions comprising polypeptides |
| 06/09/2005 | WO2005052002A2 Single-domain antibodies and uses thereof |
| 06/09/2005 | WO2005051993A1 Novel muscle growth regulator |
| 06/09/2005 | WO2005051990A2 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer |
| 06/09/2005 | WO2005051986A1 Polyvalent allergy vaccine |
| 06/09/2005 | WO2005051983A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 06/09/2005 | WO2005051455A2 Ultrasound assisted transdermal vaccine delivery method and system |
| 06/09/2005 | WO2005051421A2 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 06/09/2005 | WO2005051420A1 Novel immunogenic peptide and novel epitopes and the use thereof for producing active pharmaceutical compositions against a hepatitis c virus |
| 06/09/2005 | WO2005051419A1 Retrovirus-like particles and retroviral vaccines |
| 06/09/2005 | WO2005051414A1 Use of c4bp core region as a cd40 agonist |
| 06/09/2005 | WO2005051355A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | WO2005051330A2 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT |
| 06/09/2005 | WO2005051321A2 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase |
| 06/09/2005 | WO2005051313A2 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | WO2005051291A2 B-cell-targeted toxin for immuno response reduction |
| 06/09/2005 | WO2005051289A2 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | WO2005035773A8 Modified cea /b7 vector |
| 06/09/2005 | WO2005030136A3 Tumor vaccine |
| 06/09/2005 | WO2005028499A3 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 06/09/2005 | WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 06/09/2005 | WO2005021592A3 Enhancing the circulating half-life of interleukin-2 proteins |
| 06/09/2005 | WO2005018544A3 Therapy-enhancing glucan |
| 06/09/2005 | WO2005014039A3 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 06/09/2005 | WO2005012537A3 Adenoviral vector-based vaccines |
| 06/09/2005 | WO2005010032A3 Replikin peptides and uses thereof |
| 06/09/2005 | WO2005009462A3 Vaccine formulations comprising an oil-in-water emulsion |
| 06/09/2005 | WO2005008248A3 Diagnosis and treatment of cervical cancer |
| 06/09/2005 | WO2005003302A3 Novel methods to modulate mast cells |
| 06/09/2005 | WO2005002513A3 C1q complement inhibitors and methods of use thereof |
| 06/09/2005 | WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 06/09/2005 | WO2005000344A3 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 06/09/2005 | WO2005000227A3 Methods of treating tnf-mediated disorders |
| 06/09/2005 | WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 06/09/2005 | WO2004108756A3 Sars coronavirus peptides and uses thereof |